Since our founding in 1999, we have grown rapidly to become the ninth largest animal health group globally.
Ceva Animal Health was recognized as the fastest-growing Top 10 veterinary health company through our first 10 years of existence.
Ceva's expertise centers on the two fields of pharmacology and biology, where we have dedicated teams to meet the specific demands of the livestock, poultry, swine, equine and pet sectors. We strive to find better solutions to existing and emerging diseases which, in turn, improve animal health and productivity. A staggering 75 percent of all emerging human infectious diseases are of animal origin.
Ceva is involved in the fight against the spread of infectious disease that can be transmitted from wild or domestic animals and birds to humans—diseases known as zoonoses.
Ceva is a visible supporter of and contributor to various welfare and social programs all over the world.
Our global business operations are divided into six major zones: Western Europe, Central and Eastern Europe (including Turkey), North America, Latin America, Africa/Middle East and Asia/Pacific. We have operations in 42 countries, 13 research and development centers, 21 production sites and over 3,500 employees worldwide.